SWISS NORDIC BIO

CONNECTING HEALTHCARE INNOVATIONS, INVESTORS AND INDUSTRY

SWISS NORDIC BIO AT A GLANCE

Swiss Nordic Bio in Zurich is a high-level partnering and investor event where Swiss, Austrian and Nordic biotech and medtech startups, pharmaceutical companies and investors meet. Swiss Nordic Bio carries 20 years of tradition, previously Swiss Scandinavian Bio-Business Seminar, and is organised by the Nordic countries in cooperation with Swiss and Austrian partners.

TIME AND PLACE

When: 1 October 2026
Where: Zürich Airport, Radisson Blu Hotel

FOCUS

The conference has a broad focus within biotech, medtech and pharma (drug development, drug delivery, biomaterials, medical device, diagnostics, contract manufacturing, CRO, etc.) and gathers small, early stage companies as well as global, commercial corporations.

The conference is open for biotech, medtech and pharma companies as well as investors within the life science industry. For other types of companies other conditions apply (e.g. participation fee for business services providers is EUR 2 940), please contact the Swiss Nordic Bio organization Team at This email address is being protected from spambots. You need JavaScript enabled to view it.

PARTICIPATION FEE AND REGISTRATION

Participation Fee

General Admission Private SME Company:

EUR 1170 standard price (EUR 585 subsidised fee).
At the moment SMEs from following countries are eligible for subsidised fee: Norway, Sweden, Austria and Switzerland.

Investor / Business Developer / Innovation Scout: Free of charge

Business Service Provider: EUR 2 940

Partnership / Sponsorship / Co-organiser: To learn more about the partnership & sponsorship opportunities, please contact This email address is being protected from spambots. You need JavaScript enabled to view it..

For more information about participation fee please see the Terms of Service.

REGISTRATION

IMPORTANT DEADLINES

End of registration
30 September 2026

1-to-1 meeting booking opens
August 2026

Event date
1 October 2026